Hamlet BioPharma – Year-end Report (Q4) July 2025 – June 2026
Preview text: Hamlet BioPharma – Year-end Report (Q4) July 2025 – June 2026
Image not available
No image available for this email.
- Subject
- Hamlet BioPharma – Year-end Report (Q4) July 2025 – June 2026
- Preview text
- Hamlet BioPharma – Year-end Report (Q4) July 2025 – June 2026
- From
- info@
hamletbiopharma.com - Brand
- Hamlet BioPharma
- ESP
- Mailchimp
- Sent
- Fri Aug 28, 2026, 3:15 AM ET
- Size
- 54 KB
- Images
- 10
- Links
- 9, 2 of them buttons
- Subject length
- 61 characters
Against Hamlet BioPharma's usual
Sent in the 3 AM hour, which holds 13% of its emails; 16% arrive in the 4 AM hour. The subject is 61 characters; its average is 47.
Sent just before and after
| Sep 21, 2026 11:07 AM | BAMLET treatment strengthens metabolic health | |
| Sep 21, 2026 4:39 AM | PRESS RELEASE Lund, September 21st, 2026 | |
| Sep 17, 2026 3:38 AM | PRESS RELEASE – Lund, September 17th 2026 | |
| Aug 28, 2026 3:15 AM | Hamlet BioPharma – Year-end Report (Q4) July 2025 – June 2026 (this email) | |
| Aug 27, 2026 6:15 AM | Hamlet BioPharma bjuder in till pressträff den 28 augusti 2026 | |
| Aug 5, 2026 11:25 AM | Pressrelease – Lund, 8 Augusti, 2026 | |
| Jul 28, 2026 7:11 AM | PRESSRELEASE Lund, July 28th, 2026 |
More from Hamlet BioPharma
All Hamlet BioPharma emailsBladder cancer treatment with Alpha1H Highlighted in International Scientific Publication
Nov 10, 2026 9:52 AM
Blåscancerbehandling med Alpha1H uppmärksammas i internationell vetenskaplig publikation
Nov 10, 2026 9:49 AM
Nov 9, 2026 5:45 AM
Hamlet BioPharma publicerar årsredovisning 2025/2026
Oct 30, 2026 4:01 AM
PRESS RELEASE Lund, October 28th, 2026
Oct 28, 2026 6:09 AM
